OTCMKTS:VYCO Vycor Medical (VYCO) Stock Price, News & Analysis → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free VYCO Stock Alerts $0.08 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.08▼$0.0850-Day Range$0.08▼$0.0952-Week Range$0.04▼$0.10VolumeN/AAverage Volume14,221 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Vycor Medical alerts: Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Vycor Medical Stock (OTCMKTS:VYCO)Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.Read More VYCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VYCO Stock News HeadlinesApril 28, 2024 | americanbankingnews.comVycor Medical, Inc. (OTCMKTS:VYCO) Short Interest Down 30.0% in AprilJanuary 7, 2023 | finance.yahoo.comVycor Medical, Inc. (VYCO)May 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.November 1, 2022 | health.usnews.comMedical Review BoardSeptember 8, 2022 | reuters.comVycor Medical IncDecember 17, 2021 | nasdaq.comVycor Medical Inc (VYCO)See More Headlines Receive VYCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/17/2020Today5/04/2024Next Earnings (Estimated)5/12/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:VYCO CUSIP92921M203 CIK1424768 Webwww.vycormedical.com Phone(561) 558-2000FaxN/AEmployees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Peter C. Zachariou (Age 62)CEO & Director Mr. David Marc Cantor (Age 58)President & Director Mr. Adrian Christopher Liddell (Age 65)Chairman & CFO Key CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors VYCO Stock Analysis - Frequently Asked Questions How have VYCO shares performed in 2024? Vycor Medical's stock was trading at $0.0772 at the beginning of 2024. Since then, VYCO shares have increased by 8.8% and is now trading at $0.0840. View the best growth stocks for 2024 here. Are investors shorting Vycor Medical? Vycor Medical saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 700 shares, a decrease of 30.0% from the March 31st total of 1,000 shares. Based on an average daily volume of 4,300 shares, the days-to-cover ratio is currently 0.2 days. View Vycor Medical's Short Interest. When is Vycor Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Sunday, May 12th 2024. View our VYCO earnings forecast. How were Vycor Medical's earnings last quarter? Vycor Medical, Inc. (OTCMKTS:VYCO) issued its quarterly earnings results on Monday, August, 17th. The medical device company reported ($0.01) earnings per share for the quarter. The medical device company earned $0.24 million during the quarter. What other stocks do shareholders of Vycor Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Drone Aviation (DRNE), Intercept Pharmaceuticals (ICPT), Paratek Pharmaceuticals (PRTK) and Shopify (SHOP). How do I buy shares of Vycor Medical? Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VYCO) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vycor Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.